As a chromatin-level regulator of transcription, the NuRD complex may facilitate breast cancer development and progression by interacting with YAP/TAZ from the Hippo tumor-suppressor pathway39, modulating estrogen functions and the human epidermal growth factor receptor 2 pathway40, and by blocking p53-induced apoptosis40. The gene discussed is ERBB2; the disease is breast carcinoma.